or Try an Advanced Search...

    Technical Analysis for RFL - Rafael Holdings, Inc.

    Grade Last Price % Change Price Change
    F 1.53 0.00% 0.00
    RFL closed unchanged on Friday, May 31, 2024, on 56 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    Earnings due: Jun 11
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical RFL trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Stochastic Reached Oversold Weakness 0.00%
    Below Lower BB Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    MACD Bearish Signal Line Cross Bearish 0.00%
    Older End-of-Day Signals for RFL ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High 1 day ago
    Rose Above Lower Bollinger Band 1 day ago
    Up 1% 1 day ago
    Rose Above Lower Bollinger Band 3 days ago
    Down 1% 3 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    RFL Chart by TradingView
    Basic chart:

    Profile

    Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Cancer Cell Millennium Pharmaceuticals

    Is RFL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 14 Rafael Holdings reports Q2 results
    Mar 13 Rafael Holdings GAAP EPS of $0.25, revenue of $0.07M
    Mar 13 Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results
    Dec 14 Rafael Holdings GAAP EPS of -$0.15, revenue of $68K
    Dec 14 Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results
    See more RFL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.52
    52 Week Low 1.45
    Average Volume 18,416
    200-Day Moving Average 1.81
    50-Day Moving Average 1.66
    20-Day Moving Average 1.58
    10-Day Moving Average 1.57
    Average True Range 0.08
    RSI (14) 36.71
    ADX 30.82
    +DI 14.95
    -DI 19.48
    Chandelier Exit (Long, 3 ATRs) 1.50
    Chandelier Exit (Short, 3 ATRs) 1.74
    Upper Bollinger Bands 1.64
    Lower Bollinger Band 1.53
    Percent B (%b) 0.03
    BandWidth 7.25
    MACD Line -0.03
    MACD Signal Line -0.03
    MACD Histogram -0.0028
    Fundamentals Value
    Market Cap 36.29 Million
    Num Shares 23.7 Million
    EPS -0.29
    Price-to-Earnings (P/E) Ratio -5.28
    Price-to-Sales 161.02
    Price-to-Book 0.46
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.59
    Resistance 3 (R3) 1.60 1.58 1.58
    Resistance 2 (R2) 1.58 1.57 1.58 1.58
    Resistance 1 (R1) 1.56 1.56 1.55 1.55 1.57
    Pivot Point 1.54 1.54 1.54 1.54 1.54
    Support 1 (S1) 1.52 1.53 1.51 1.51 1.49
    Support 2 (S2) 1.50 1.52 1.50 1.48
    Support 3 (S3) 1.48 1.50 1.48
    Support 4 (S4) 1.47